| 1M14 | A: | TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR |
| 1M17 | A: | EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAIN WITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB |
| 1XKK | A: | EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR-GW572016 |
| 2EB2 | A: | CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (G719S) |
| 2EB3 | A: | CRYSTAL STRUCTURE OF MUTATED EGFR KINASE DOMAIN (L858R) IN COMPLEX WITH AMPPNP |
| 2GS2 | A: | CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN |
| 2GS6 | A: | CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AN ATP ANALOG-PEPTIDE CONJUGATE |
| 2GS7 | A:; B: | CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP |
| 2ITY | A:697-1018 | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH IRESSA |
| 2RFE | D: | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE EGFR KINASE DOMAIN AND A MIG6 PEPTIDE |
| 2RGP | A: | STRUCTURE OF EGFR IN COMPLEX WITH HYDRAZONE, A POTENT DUAL INHIBITOR |
| 3BEL | A: | X-RAY STRUCTURE OF EGFR IN COMPLEX WITH OXIME INHIBITOR |
| 3GT8 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP |
| 3IKA | A:; B: | CRYSTAL STRUCTURE OF EGFR 696-1022 T790M MUTANT COVALENTLY BINDING TO WZ4002 |
| 3POZ | A: | EGFR KINASE DOMAIN COMPLEXED WITH TAK-285 |
| 3UG1 | A: | CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN THE APO FORM |
| 3UG2 | A: | CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN COMPLEX WITH GEFITINIB |
| 3VJN | A: | CRYSTAL STRUCTURE OF THE MUTATED EGFR KINASE DOMAIN (G719S/T790M) IN COMPLEX WITH AMPPNP. |
| 3VJO | A: | CRYSTAL STRUCTURE OF THE WILD-TYPE EGFR KINASE DOMAIN IN COMPLEX WITH AMPPNP. |
| 3W2O | A: | EGFR KINASE DOMAIN T790M/L858R MUTANT WITH TAK-285 |
| 3W2P | A: | EGFR KINASE DOMAIN T790M/L858R MUTANT WITH COMPOUND 2 |
| 3W2Q | A: | EGFR KINASE DOMAIN T790M/L858R MUTANT WITH HKI-272 |
| 3W2R | A: | EGFR KINASE DOMAIN T790M/L858R MUTANT WITH COMPOUND 4 |
| 3W2S | A: | EGFR KINASE DOMAIN WITH COMPOUND4 |
| 3W32 | A: | EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 20A |
| 3W33 | A: | EGFR KINASE DOMAIN COMPLEXED WITH COMPOUND 19B |
| 4HJO | A: | CRYSTAL STRUCTURE OF THE INACTIVE EGFR TYROSINE KINASE DOMAIN WITH ERLOTINIB |
| 4I22 | A: | STRUCTURE OF THE MONOMERIC (V948R)GEFITINIB/ERLOTINIB RESISTANT DOUBLE MUTANT (L858R+T790M) EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH GEFITINIB |
| 4I23 | A: | CRYSTAL STRUCTURE OF THE WILD-TYPE EGFR KINASE DOMAIN IN COMPLEX WITH DACOMITINIB (SOAKED) |
| 4I24 | A:; B: | STRUCTURE OF T790M EGFR KINASE DOMAIN CO-CRYSTALLIZED WITH DACOMITINIB |
| 4JQ7 | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 2A |
| 4JQ8 | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 4B |
| 4JR3 | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 3G |
| 4JRV | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH COMPOUND 4C |
| 4LI5 | A: | EGFR-K IN COMPLEX WITH N-[3-[[5-CHLORO-4-(1H-INDOL-3-YL)PYRIMIDIN-2-YL]AMINO]-4-METHOXY-PHENYL] PROP-2-ENAMIDE |
| 4LQM | A: | EGFR L858R IN COMPLEX WITH PD168393 |
)
)